stoxline Quote Chart Rank Option Currency Glossary
  
RenovoRx, Inc. (RNXT)
1.05  0.095 (9.96%)    11-17 13:24
Open: 0.995
High: 1.05
Volume: 348,783
  
Pre. Close: 0.9549
Low: 0.9601
Market Cap: 51(M)
Technical analysis
2026-11-17 12:49:20 PM
Short term     
Mid term     
Targets 6-month :  1.51 1-year :  1.81
Resists First :  1.29 Second :  1.54
Pivot price 1.21
Supports First :  0.87 Second :  0.73
MAs MA(5) :  1.08 MA(20) :  1.23
MA(100) :  1.3 MA(250) :  1.07
MACD MACD :  -0.1 Signal :  -0.1
%K %D K(14,3) :  19.6 D(3) :  28
RSI RSI(14): 37.9
52-week High :  2.58 Low :  0.73
Price, MAs and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.
[ RNXT ] has closed above bottom band by 18.9%. Bollinger Bands are 2.2% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 1.06 - 1.07 1.07 - 1.07
Low: 0.88 - 0.89 0.89 - 0.9
Close: 0.94 - 0.96 0.96 - 0.97
Company Description

RenovoRx, Inc. is a clinical-stage biopharmaceutical firm dedicated to developing therapies for solid tumor malignancies. The company's primary investigational therapy, RenovoGem, is an innovative drug and device combination. It integrates intra-arterial gemcitabine with the RenovoCath system, currently progressing through pivotal Phase III clinical trials for the treatment of locally advanced pancreatic cancer. Established in 2009, RenovoRx, Inc. maintains its headquarters in Los Altos, California.

Headline News

Tue, 17 Nov 2026
RenovoRx (RNXT) chairman buys shares, bringing direct holdings to 848,460. - Stock Titan

Wed, 11 Nov 2026
Renovorx Stock Price Forecast. Should You Buy RNXT? - StockInvest.us

Thu, 05 Nov 2026
RenovoRx, Inc. (RNXT) Reports Q3 Loss, Tops Revenue Estimates - Yahoo Finance

Wed, 12 Aug 2026
RenovoRx Inc (RNXT) (Q2 2026) Earnings Call Highlights: Record Revenue and Strategic Expansion ... - Yahoo Finance

Wed, 12 Aug 2026
RenovoRx, Inc. (RNXT) Reports Q2 Loss, Beats Revenue Estimates - Yahoo Finance

Tue, 28 Jul 2026
RenovoRx, Inc. (NASDAQ:RNXT): Are Analysts Optimistic? - Simply Wall St

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Underperform
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Underperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Neutral
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Underperform
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Underperform
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Outperform
Stock Basics & Statistics
Exchange:
NASDAQ
Sector:
Healthcare
Industry:
Biotechnology
Shares Out 48 (M)
Shares Float 39 (M)
Held by Insiders 3.5 (%)
Held by Institutions 20.5 (%)
Shares Short 865 (K)
Shares Short P.Month 674 (K)
Stock Financials
EPS -0.32
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 0.15
Profit Margin 0 %
Operating Margin -368.5 %
Return on Assets (ttm) -65 %
Return on Equity (ttm) -125.3 %
Qtrly Rev. Growth 115.4 %
Gross Profit (p.s.) 0.03
Sales Per Share 0.04
EBITDA (p.s.) -0.28
Qtrly Earnings Growth 0 %
Operating Cash Flow -12 (M)
Levered Free Cash Flow -7 (M)
Stock Valuations
PE Ratio -3.36
PEG Ratio 0
Price to Book value 6.93
Price to Sales 25.34
Price to Cash Flow -4.23
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

Stoxline iOS

Alpha Bridge iOS

OptionCalc iOS

StockChart Android

Stoxline Android

Alpha Bridge Android

OptionCalc Android